Chemed to Pay $75 Million to Settle False Claims Lawsuit
Posted 10/31/17
By the C|C Whistleblower Lawyer Team
Chemed, and its wholly-owned subsidiary, Vitas, have agreed to pay $75 million to resolve a government lawsuit brought under the False Claims Act (FCA). According to the DOJ’s press release, the settlement resolves allegations that between 2002 and 2013 Vitas submitted false claims to Medicare for services to hospice patients who were not terminally ill.
The government’s...